Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Saved in:
| Title: | Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI. |
|---|---|
| Authors: | Kraft, Colleen S.1 (AUTHOR), Sims, Matthew2,3 (AUTHOR), Silverman, Michael4 (AUTHOR), Louie, Thomas J.5 (AUTHOR), Feuerstadt, Paul6,7 (AUTHOR), Huang, Edward S.8 (AUTHOR), Khanna, Sahil9 (AUTHOR), Berenson, Charles S.10 (AUTHOR), Wang, Elaine E. L.11 (AUTHOR), Cohen, Stuart H.12 (AUTHOR), Korman, Louis13 (AUTHOR), Lee, Christine14 (AUTHOR), Kelly, Colleen R.15 (AUTHOR), Odio, Alberto16 (AUTHOR), Cook, Paul P.17 (AUTHOR), Lashner, Bret18 (AUTHOR), Ramesh, Mayur19 (AUTHOR), Kumar, Princy20 (AUTHOR), De, Ananya11 (AUTHOR), Memisoglu, Asli11 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Oct2024, Vol. 13 Issue 10, p2209-2210. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
